IP Library Granted Patent US 10,351,906
Granted Patent B2
US 10,351,906 · App. 15/336,630 · Granted Jul 16, 2019

Methods for simultaneous amplification of target loci

Inventors: Bernhard Zimmermann (San Mateo, CA); Matthew Hill (Redwood City, CA); Philippe Lacroute (Sunnyvale, CA); Michael Dodd (San Francisco, CA); Alexander Wong (Mountain View, CA)
Assignee: Natera, Inc.
C12Q1/686C12Q1/68C12Q1/6811C12Q1/6848C12Q1/6874C12Q1/6883C12Q2600/156
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,351,906
App. No.
15/336,630
Granted
Jul 16, 2019
Kind
B2
Abstract

The invention provides methods for simultaneously amplifying multiple nucleic acid regions of interest in one reaction volume as well as methods for selecting a library of primers for use in such amplification methods. The invention also provides library of primers with desirable characteristics, such as minimal formation of amplified primer dimers or other non-target amplicons.

Claims (26)

1. A method of amplifying target loci in a nucleic acid sample, the method comprising:

(a) contacting a sample comprising target loci with a library of at least 50 non-immobilized, non-identical PCR primers that simultaneously hybridize to at least 50 non-identical target loci to produce a reaction mixture; and

(b) subjecting the reaction mixture to PCR conditions to produce amplified products comprising target amplicons; wherein an annealing temperature for the PCR conditions is greater than a melting temperature for at least 95% of the at least 50 non-identical PCR primers; wherein a length of an annealing step of the PCR conditions is greater than 5 minutes; and wherein at least 50 non-identical target loci are simultaneously amplified.

2. The method of claim 1 , wherein the lengths of the target amplicons are between 30 and 200 nucleotides and wherein the concentration of each primer in the library is less than 20 nM.

3. The method of claim 1 , wherein the annealing temperature is 1 to 15° C. greater than the highest melting temperature of at least 95% of the at least 50 non-identical primers.

4. The method of claim 1 , wherein the library comprises at least 1000 non-immobilized, non-identical primer pairs that simultaneously hybridize to at least 1000 non-identical target human loci, wherein the annealing temperature for the PCR conditions is greater than a melting temperature of at least 90% of the at least 1000 non-identical primers, and wherein the at least 1000 non-identical target loci are simultaneously amplified.

5. The method of claim 1 , wherein the length of the annealing step of the PCR conditions is between 10 and 60 minutes.

6. The method of claim 1 , wherein the AG values for each possible combination of two primers in the library are all equal to or greater than −5 kcal/mol.

7. The method of claim 1 , further comprising performing universal amplification on nucleic acids in the sample prior to step (a), and further comprising sequencing the amplified products comprising target amplicons after step (b).

8. The method of claim 1 , wherein at least 90% of the amplified products are target amplicons, and wherein the range of melting temperatures of the at least 50 non-identical primers is less than 5° C.

9. The method of claim 1 , wherein at least 90% of the target loci are amplified and wherein less than 20% of the amplified products are primer dimers.

10. A method of amplifying target loci in a nucleic acid sample, the method comprising:

(a) contacting a sample comprising target loci with a library of at least 50 non-immobilized, non-identical PCR primers that simultaneously hybridize to at least 50 non-identical target loci to produce a reaction mixture, wherein the sample is derived from blood; and

(b) subjecting the reaction mixture to PCR conditions to produce amplified products comprising target amplicons, wherein the annealing temperature for the PCR conditions is greater than a melting temperature for at least 95% of the at least 50 non-identical PCR primers, wherein the melting temperature is a calculated temperature at which one-half of a DNA duplex of a primer and its perfect complement is predicted to dissociate and become single stranded DNA, wherein the length of an annealing step of the PCR conditions is between 5 and 60 minutes, wherein the length of the target amplicons is between 30 and 200 nucleotides, and wherein at least 50 non-identical target human loci are simultaneously amplified.

11. The method of claim 10 , wherein the sample is from an individual suspected of having cancer.

12. The method of claim 10 , wherein the sample comprises maternal DNA from the pregnant mother of a fetus and fetal DNA.

13. The method of claim 10 , wherein the melting temperature of at least 90% of the primers is between 54 and 60.5, inclusive, and the annealing temperature is between 60° C. and 70° C., inclusive.

14. The method of claim 10 , wherein the annealing temperature is 1 to 10° C. greater than the highest melting temperature of at least 95% of the at least 50 non-identical primers.

15. The method of claim 10 , wherein the library comprises between 10,000 and 100,000 non-immobilized, non-identical primers or primer pairs that simultaneously hybridize to the at least 10,000 and 100,000 non-identical target human loci, wherein the annealing temperature for the PCR conditions is greater than a melting temperature of at least 90% of the between 10,000 and 100,000 non-identical primers, and wherein between 10,000 and 100,000 non-identical target human loci are simultaneously amplified.

16. A method of amplifying target loci in a nucleic acid sample, the method comprising:

(a) contacting a sample comprising target loci with a library of between 10,000 and 100,000 non-immobilized, non-identical PCR primers or primer pairs that simultaneously hybridize to between 10,000 and 100,000 non-identical target loci to produce a reaction mixture, wherein the concentration of each primer in the reaction mixture is less than 20 nM; and

(b) subjecting the reaction mixture to PCR conditions to produce amplified products comprising target amplicons, wherein an annealing temperature for the PCR conditions is greater than a melting temperature for at least 95% of primers of the 10,000 to 100,000 non-identical PCR primers or primer pairs, wherein the length of an annealing step of the PCR conditions is between 5 and 60 minutes, and wherein between 10,000 and 100,000 non-identical target loci are simultaneously amplified.

17. The method of claim 16 , wherein the melting temperature of at least 90% of primers of the PCR primers or primer pairs is between 50° C. and 60.5° C., inclusive, and the annealing temperature is between 60° C. and 70° C., inclusive.

18. The method of claim 16 , wherein the length of at least 95% of primers of the PCR primers or primer pairs is between 15 to 40 nucleotides, inclusive, the length of at least 95% of the target amplicons is between 30 and 200 nucleotides, and the concentration of at least 95% of primers of the PCR primers or primer pairs is less than 10 nm.

19. The method of claim 16 , wherein the annealing temperature is 1 to 10° C. greater than the highest melting temperature of at least 95% of primers of the PCR primers or primer pairs.

20. The method of claim 16 , wherein the annealing temperature is at least 3° C. greater than the highest melting temperature of at least 90% of primers of the PCR primers or primer pairs.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 22, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: NATERA, INC.
Reel/Frame 052472/0712 →
SECURITY INTEREST Recorded Aug 8, 2017
From: NATERA, INC.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 043482/0472 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2017
From: ZIMMERMANN, BERNHARD; HILL, MATTHEW; DODD, MICHAEL; WONG, ALEXANDER
To: NATERA, INC.
Reel/Frame 042999/0768 →
PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT Recorded Jul 13, 2017
From: LACROUTE, PHILIPPE
To: GENE SECURITY NETWORK, INC.
Reel/Frame 043183/0684 →
CHANGE OF NAME Recorded Jul 13, 2017
From: GENE SECURITY NETWORK INC.
To: NATERA, INC.
Reel/Frame 043183/0768 →
Continuity (6)
Continuation 14538982 · Nov 24, 2014
Provisional Application 62066514 · Oct 21, 2014
Provisional Application 61994791 · May 16, 2014
Provisional Application 61987407 · May 1, 2014
Provisional Application 61982245 · Apr 21, 2014
Related Publication 20170145474A1 · May 25, 2017
Cited By (31)
US 12,203,142 US 12,221,653 US 12,234,509 US 12,260,934 US 12,270,073 US 12,305,229 US 12,305,235 US 12,385,096 US 12,410,476 US 12,460,264 US 12,486,542 US 12,492,429 US 12,494,267 US 12,509,728 US 12,509,730 US 12,545,960 US 12,553,083 US 12,553,086 US 12,553,087 US 12,571,034 US 12,571,043 US 12,571,047 US 12,584,175 US 12,644,149 US 12,649,946 US 12,655,483 US 12,662,704 US 12,668,843 US 12,692,544 US 12,716,090 US 12,716,100